KLP Investment

CEO Kim Ki-hwan, the firm's founder and former LG Group strategist, leads all investment committee decisions. Day-to-day deal execution is managed by a compact team of senior directors. Kim's tenure spans the firm's entire operational history since 2002, making succession a closely watched variable among LPs considering re-up commitments.

Primarily direct equity investments at the Series A through pre-IPO stages, with selected participation in domestic fund-of-funds structures and separately managed accounts for Korean pension and insurance LPs. The firm occasionally engages in special-situation secondary purchases when portfolio companies require liquidity. KLP does not operate as a fund-of-funds allocator or commit substantially to third-party GPs.

Early-stage through expansion and pre-IPO rounds, with check sizes ranging from approximately $2M to $20M. The firm leads or co-leads most of its Series A and Series B participations and selectively reserves capital for growth-stage follow-ons. Seed-stage activity is present but not the firm's primary allocation.

No philanthropic foundation or donor-advised fund is publicly associated with KLP Investment or Kim Ki-hwan. The firm's corporate structure and investor communications do not reference charitable distributions or impact-first allocations. Any personal philanthropic activity by the founder would be separate from the firm's investment mandate.

The firm manages blind-pool funds and separate accounts for institutional LPs including Korean pension funds and insurance companies, often alongside Korea Venture Investment Corp.-backed fund-of-funds vehicles. This government-linked participation anchors KLP's LP base, with shorter-tenor private capital forming the balance. The structure places KLP squarely within the domestic LP ecosystem rather than relying primarily on North American or European limited partners.

KLP concentrates on enterprise software, AI/ML, fintech, digital health, and mobility. The firm has not publicly pursued deep-tech hardware, biotech therapeutics, industrial manufacturing, real estate, or natural resources. This avoidance pattern reflects both Kim's expertise band and the firm's thesis that Korean technology exits cluster around platform-layer and consumer-facing software businesses rather than hard-science commercialization.

KLP frequently syndicates with Japan- and Singapore-based VCs and occasional Silicon Valley co-investors on larger growth rounds. The firm's structure as a domestic-first GP makes co-investment a bridge to international networks rather than a dependency. LP co-investment rights are available case-by-case, typically reserved for cornerstone investors in each fund vehicle.